Indivior Pharmaceuticals, Inc. INDV Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's non-cash lease expense?
- Indivior Pharmaceuticals, Inc. (INDV) reported non-cash lease expense of $2M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's non-cash lease expense changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's non-cash lease expense decreased by 0.0% year-over-year, from $2M to $2M.
- What does non-cash lease expense mean?
- Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.